Screening and monitoring both get mentioned in these presentations - but its confusing why and how these terms get used.
Clearly they have 2 massively different implications.
For example in breast cancer - Screening is for any woman (to check for incidence) - whilst monitoring is only for those who have been diagnosed (to chart their recovery).
Hugely different addressable markets!!!
Check out the timelines in the decks - only talk about breast and ovarian monitoring.
But elsewhere they mention screening.
On another line in the timeline they mention pan-cancer screening.
Anybody not confused by this?
Screening and monitoring both get mentioned in these...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.010(1.87%) |
Mkt cap ! $48.31M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.5¢ | 52.5¢ | $12.70K | 24.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7685 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 6500 | 1 |
View Market Depth
| Last trade - 15.42pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
52.5¢ |
Change
-0.010 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 53.0¢ | 53.0¢ | 52.5¢ | 6712 | ||
| Last updated 11.43am 26/04/2024 ? | |||||
| IIQ (ASX) Chart |